Not Rated
|
Fund Size
(0.37% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 20-Oct-25 | 9942.80 | -0.57% | - | 0.35% | 204/226 |
| 1 Month | 26-Sep-25 | 10334.10 | 3.34% | - | 3.99% | 144/227 |
| 3 Month | 25-Jul-25 | 9819.90 | -1.80% | - | 3.69% | 216/223 |
| 6 Month | 25-Apr-25 | 10884.90 | 8.85% | - | 11.44% | 138/213 |
| YTD | 01-Jan-25 | 10215.00 | 2.15% | - | 5.58% | 128/201 |
| 1 Year | 25-Oct-24 | 11067.10 | 10.67% | 10.61% | 6.91% | 49/184 |
| 2 Year | 27-Oct-23 | 18022.40 | 80.22% | 34.19% | 22.92% | 4/141 |
| Since Inception | 04-Oct-23 | 17787.30 | 77.87% | 32.15% | 14.63% | 6/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 25-Oct-24 | 12000 | 12837.16 | 6.98 % | 13.14 % |
| 2 Year | 27-Oct-23 | 24000 | 29791.26 | 24.13 % | 22.29 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 1984.3 | 10.47% | 0.08% | 14.02% (Oct 2024) | 10.39% (Aug 2025) | 12.45 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 1470.7 | 7.76% | -0.54% | 10.24% (May 2025) | 7.18% (Dec 2024) | 2.58 L | 0.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1313.8 | 6.93% | 0.15% | 7.42% (Jul 2025) | 2.92% (Oct 2024) | 6.73 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 1296.4 | 6.84% | 0.11% | 6.84% (Sep 2025) | 5.35% (Jan 2025) | 6.78 L | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 1125.8 | 5.94% | 2.00% | 5.94% (Sep 2025) | 0% (Oct 2024) | 2.08 L | 65.85 k |
| Max Healthcare Institute Ltd. | Hospital | 882.8 | 4.66% | 1.40% | 4.95% (Jan 2025) | 1.8% (Oct 2024) | 7.92 L | 2.53 L |
| Ipca Laboratories Ltd. | Pharmaceuticals | 853.3 | 4.50% | -0.12% | 4.62% (Aug 2025) | 3.26% (Mar 2025) | 6.37 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 818.3 | 4.32% | -2.24% | 8.17% (Oct 2024) | 4.32% (Sep 2025) | 5.44 L | -2.44 L |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 722.8 | 3.81% | 0.07% | 3.88% (Jul 2025) | 2.26% (Oct 2024) | 2.01 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 689.4 | 3.64% | -0.09% | 4.04% (Mar 2025) | 3.25% (Oct 2024) | 9.85 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.05% |
| Net Receivables | Net Receivables | -0.06% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 406.67 | 6.43 | 27.67 | 77.85 | 44.53 | 44.44 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 266.19 | 2.02 | 7.96 | 24.03 | 29.36 | 18.84 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 289.73 | 1.57 | 7.21 | 18.02 | 24.66 | 20.27 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 3.76 | 5.26 | 22.51 | 24.04 | 0.00 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 6.39 | 6.22 | 23.73 | 23.87 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 1.38 | 12.33 | 30.64 | 21.73 | 0.00 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 6.40 | 6.01 | 11.42 | 21.58 | 0.00 |
| Motilal Oswal Business Cycle Fund - Direct Plan - Growth | NA | 1984.52 | 7.38 | 7.27 | 15.41 | 20.14 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 3.27 | 9.54 | 26.13 | 19.67 | 18.24 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 8693.07 | 5.83 | 4.73 | 11.76 | 19.49 | 20.32 |
Out of 86 mutual fund schemes offered by this AMC, 5 is/are ranked 5 * , 6 is/are ranked 4 * , 11 is/are ranked 3 * , 6 is/are ranked 2 * , 1 is/are ranked 1 * , and 57 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| HDFC Balanced Advantage Fund - Direct Plan - Growth | 4 | 103041.31 | 3.29 | 3.16 | 6.99 | 7.38 | 19.64 |
| HDFC Flexi Cap Fund - Direct Plan - Growth | 5 | 85559.59 | 3.65 | 5.51 | 9.78 | 11.58 | 23.47 |
| HDFC Mid Cap Fund - Direct Plan - Growth | 4 | 84854.73 | 5.46 | 3.47 | 14.10 | 10.31 | 27.05 |
| HDFC Liquid Fund - Direct Plan - Growth | 3 | 56061.67 | 0.49 | 1.43 | 3.00 | 6.78 | 7.06 |
| HDFC Large Cap Fund - Direct Plan - Growth | 3 | 38251.04 | 4.27 | 3.03 | 6.77 | 5.20 | 17.36 |
| HDFC Money Market Fund - Direct Plan - Growth | 3 | 37139.08 | 0.54 | 1.48 | 3.43 | 7.76 | 7.68 |
| HDFC Small Cap Fund - Direct Plan - Growth | 4 | 36827.67 | 2.62 | 1.70 | 16.70 | 8.73 | 24.27 |
| HDFC Corporate Bond Fund - Direct Plan - Growth | 2 | 35574.35 | 0.84 | 1.21 | 2.96 | 8.10 | 8.19 |
| HDFC Large and Mid Cap Fund - Direct Plan - Growth | 4 | 26949.33 | 4.92 | 3.64 | 11.01 | 7.85 | 22.04 |
| HDFC Low Duration Fund - Direct Plan - Growth | 2 | 24466.14 | 0.63 | 1.55 | 3.61 | 7.98 | 7.90 |